-
U.S. court ruling against DNA patent means money saved for Canadian healthcare
A U.S. Supreme Court ruling that says you can’t “own” DNA is a reason to celebrate for both our patients and innovative researchers. America’s highest court has ruled unanimously that “products of nature” cannot be patented. The ruling overturned a lower federal court decision to allow Myriad Genetics’ patent of two human genes—BRCA1 and BRCA2. This is going to have a positive effect on both cancer testing costs and genetic testing more generally. -
Baby boomers looking to right public health care, not drain it
Should we baby boomers be feeling guilty now that everyone else seems to have finally clued into the developed world’s worst-kept secret: there are lots of us, we didn’t have enough children of our own to replenish the taxpayer base, and we didn’t contribute enough in taxes to cover our future health needs as increasingly frail citizens.